← Leaderboards
Susanna McColley
Northwestern University
$185,264
Attributed
$185,264
Total exposure
6
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $96.4K · FY2005–07$100K$75K$50K$25K$0
'05
'06
'07
Funding mix
By agency
NIH$185,264 · 6
By mechanism
M01$185,264 · 6
Top collaborators
No co-investigators on record.
Most similar at Northwestern University
Same institution · by research overlap
- David D McPherson$77,387,749
- Vadim Backman$34,873,053
- Leena Sharma$24,004,363
- Marek-Marsel M Mesulam$28,227,526
- Robert L. Murphy$48,634,037
Others in their field
Top investigators on “Bacterial Disease”
- Myron Max Levine · University Of Maryland Baltimore$116,795,600
- Barbara Driver · Westat, Inc.$95,592,456
- Timothy Henkel · Venatorx Pharmaceuticals, Inc.$48,397,895
- Clarence Buddy Creech · Vanderbilt University Medical Center$43,812,829
- Ryan Cirz · Revagenix, Inc.$40,209,479
- Donald Ym Leung · University Of Colorado Denver$38,763,371
Research focus
Bacterial DiseaseClinical ResearchCystic FibrosisEarly DiagnosisHuman SubjectMycobacteriumPathologic Process
Grant awards (6)
PSEUDOMONAS AERUGINOSA TYPE III SECRETION IN CYSTIC FIBROSIS$96,422
M01 · FY2007 · RR · contact PI
ORAL THERACLECTM-TOTAL IN CYSTIC FIBROSIS SUBJECTS WITH PANCREATIC INSUFFICIENCY$22,807
M01 · FY2006 · RR · contact PI
ORAL THERACLECTM-TOTAL IN CYSTIC FIBROSIS SUBJECTS WITH PANCREATIC INSUFFICIENCY$20,695
M01 · FY2006 · RR · contact PI
ORAL THERACLECTM-TOTAL IN CYSTIC FIBROSIS SUBJECTS WITH PANCREATIC INSUFFICIENCY$16,577
M01 · FY2005 · RR
ORAL THERACLECTM-TOTAL IN CYSTIC FIBROSIS SUBJECTS WITH PANCREATIC INSUFFICIENCY$8,289
M01 · FY2005 · RR
NONTUBERCULOUS MYCOBACTERIA IN PATIENTS WITH CYSTIC FIBROSIS$20,474
M01 · FY2000 · RR